Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis

(2025) Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of Neurology. p. 25. ISSN 0340-5354

Full text not available from this repository.

Abstract

Background/Objective Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are neuroinflammatory conditions with overlapping clinical and imaging features. Distinguishing between these diseases is crucial for appropriate diagnosis and management. Magnetic resonance imaging (MRI) may have the potential to differentiate these disorders. Nonetheless, studies exhibit inconsistencies regarding which MRI measurements most effectively distinguish between these disorders. Hence, this review aimed to evaluate the differences in MRI volumetry between people with MS (PwMS) and people with NMOSD (PwNMOSD). Methods A systematic search was conducted across PubMed/MEDLINE, Embase, Scopus, and Web of Science up to May 12, 2024, to identify studies assessing conventional and volumetric MRI in PwMS and PwNMOSD. The standard mean difference (SMD) of MRI measurements and its 95 confidence interval (CI) were estimated using R version 4.4.0 with a random-effects model. Results Forty-eight original studies that assessed conventional MRI measurements in 2592 PwMS and 1979 PwNMOSD were included. The meta-analysis revealed that PwMS had significantly higher T2 lesion volume (SMD = 1.51, 95 CI: 0.53 to 2.48, p = 0.002) and T1 lesion count (SMD = 1.08, 95 CI: 0.56 to 1.6, p < 0.001) than PwNMOSD. PwMS also exhibited significantly reduced thalamic volume (SMD = -1.26, 95 CI: -1.8 to -0.73, p < 0.001) and grey matter volume (GMV) (SMD = -0.65, 95 CI: -0.92 to -0.37, p < 0.001). Other MRI volumetry, such as the brain and putamen volumes, showed more pronounced atrophy in PwMS. Conclusion Significant differences in MRI volumetry between MS and NMOSD highlight the potential of MRI as a critical diagnostic tool. These findings emphasize the need for standardized MRI protocols and advanced imaging techniques to enhance diagnostic accuracy and clinical management of these conditions.

Item Type: Article
Keywords: Multiple sclerosis Neuromyelitis optica spectrum disorder Magnetic resonance imaging Diagnosis diagnostic-criteria matter lesions white-matter brain mri neuritis atrophy disability patterns abnormalities Neurosciences & Neurology
Page Range: p. 25
Journal or Publication Title: Journal of Neurology
Journal Index: ISI
Volume: 272
Number: 1
Identification Number: https://doi.org/10.1007/s00415-024-12827-x
ISSN: 0340-5354
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/31237

Actions (login required)

View Item View Item